Financial results - SPRINTEAN PHARM SRL

Financial Summary - Sprintean Pharm Srl
Unique identification code: 29228245
Registration number: J30/791/2011
Nace: 4773
Sales - Ron
60.219
Net Profit - Ron
2.546
Employees
1
Open Account
Company Sprintean Pharm Srl with Fiscal Code 29228245 recorded a turnover of 2024 of 60.219, with a net profit of 2.546 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sprintean Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 34.428 31.396 35.018 41.691 49.678 41.059 52.652 46.795 - 60.219
Total Income - EUR 35.341 32.136 36.020 42.612 49.692 41.075 52.684 46.844 - 60.231
Total Expenses - EUR 33.268 30.419 34.657 44.747 54.486 44.485 48.942 58.210 - 57.227
Gross Profit/Loss - EUR 2.073 1.717 1.363 -2.135 -4.794 -3.410 3.742 -11.366 - 3.004
Net Profit/Loss - EUR 1.013 1.074 1.003 -2.561 -5.307 -3.783 3.210 -11.829 - 2.546
Employees 1 1 1 1 2 2 1 1 - 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 29.8%, from 46.795 euro in the year 2022, to 60.219 euro in 2024. The Net Profit increased by 2.546 euro, from 0 euro in 2022, to 2.546 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Sprintean Pharm Srl

Rating financiar

Financial Rating -
SPRINTEAN PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sprintean Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sprintean Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sprintean Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sprintean Pharm Srl - CUI 29228245

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 15.690 15.530 15.267 20.441 20.045 19.665 19.229 19.288 - 19.122
Current Assets 11.672 10.736 13.371 10.145 11.236 16.898 15.446 47.269 - 19.058
Inventories 3.914 4.377 4.415 2.559 2.463 2.819 1.253 7.259 - 10.073
Receivables 1.873 430 2.335 4.513 3.882 4.321 13.023 33.262 - 3.349
Cash 5.885 5.928 6.621 3.073 4.890 9.758 1.170 6.748 - 5.636
Shareholders Funds -1.384 -296 712 -1.862 -7.133 -10.781 -7.331 -19.183 - 1.830
Social Capital 0 0 0 0 0 0 0 0 - 0
Debts 28.746 26.561 27.926 32.448 38.414 47.344 42.006 85.741 - 36.351
Income in Advance 0 0 0 0 0 0 0 0 - 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 19.058 euro in 2024 which includes Inventories of 10.073 euro, Receivables of 3.349 euro and cash availability of 5.636 euro.
The company's Equity was valued at 1.830 euro, while total Liabilities amounted to 36.351 euro. Equity increased by 20.848 euro, from -19.183 euro in 2022, to 1.830 in 2024.

Risk Reports Prices

Reviews - Sprintean Pharm Srl

Comments - Sprintean Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.